IL6 and metabolic syndrome: Epidemiological data have indicated that subjects with dyslipidemia are in a proinflammatory state, which is distinguished by elevated levels of cytokines, such as tumor necrosis factor-alpha (TNF-α) and IL-6 and could further promote the expression of hsCRP and CAMs [30].